跳至主要内容
临床试验/NCT00749619
NCT00749619已完成3 期

Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

Western Galilee Hospital-Nahariya1 个研究点 分布在 1 个国家开始时间: 2007年5月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
试验地点
1

研究概览

简要总结

Addition of Heparin to the Catheter Lock Solution (CLS): Taurolock-TM will improve the vascular patency compared to Taurolock-TM alone , in hemodialysis patients with Tunneled Cuffed Catheter(TCC) as vascular access.

详细描述

Bacteremia and thrombosis are the major complications of TCC used for hemodialysis.Instilation of CLS containing antibiotic-anticoagulant solution in the end of each dialysis session till the next dialysis ,can prevent Catheter related bacteremia (CRB).In previous study in our department, Taurolock-TM decreased the rate of CRB but increased the incidence of catheter malfunction.

The aim of the study is to investigate the influence of of Heparin addition to CLS-Taurolock- TM ( Taurolidine &citrate 4%) in prevention of catheter patency problems in HD patients with TCC, in addition to CRB prevention.

Methods : Patients with newly inserted TCC for HD enrolled and randomized to receive one of three CLS types : group 1- Taurolock-TM, Group 2 - Taurolock-TM and Heparin , Group 3- Heparin .Patients were followed for 6 monthes.

The objective of the study is to investigate the effect of Taurolock TM with heparin on the rate of CRB and vascular patency.

研究设计

研究类型
Interventional
主要目的
Prevention

入排标准

性别
All
接受健康志愿者

入选标准

  • Hemodialysis patients with new TCC
  • Informed Consent

排除标准

  • 未提供

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验